Infantile systemic hyalinosis: Variable grades of severity.
ANTXR2 gene mutation
infantile systemic hyalinosis
phenotype
radiology
Journal
African journal of paediatric surgery : AJPS
ISSN: 0974-5998
Titre abrégé: Afr J Paediatr Surg
Pays: India
ID NLM: 101255062
Informations de publication
Date de publication:
Historique:
entrez:
3
8
2021
pubmed:
4
8
2021
medline:
20
8
2021
Statut:
ppublish
Résumé
Infantile systemic hyalinosis (ISH) is an autosomal recessively inherited disorder. The classical natural history of the disease is characterised by hypotonia, multiple contractures, skin lesions, osteopenia, joint pain, bone fractures, persistent diarrhoea and growth deficiency. Two children manifested the severe type of ISH underwent genotypic confirmation. In order to identify which other family members have inherited the disease. We included siblings and cousins in this study. The baseline tool to study other family subjects was based on the phenotypic characterisations of each child. . Two children with the severe type of ISH showed craniosynostosis (brachycephaly and scaphocephaly) associated with multiple contractures, progressive joint osteolysis ending up with multiple joint dislocations. The full exome sequencing was carried out, revealing a previously reported heterozygous nonsense mutation с.1294С>Т and a novel heterozygous non-synonymous substitution c. 58T>A in ANTRX2 gene. Three children (sibling and cousins) manifested variable clinical manifestations relevant to ISH. Specifically, asymptoamtic skin and skeletal abnormalities of hypoplastic clavicles and 'shepherd's crook' deformity and coxa vara. It is mandatory to perform extensive family pedigree search to detect asymptomatic clinical features in siblings and cousins in families with first degree related marriages. Interestingly, in the mild and the moderate types of ISH, we observed undescribed combination of asymptomatic skin and skeletal abnormalities. This is a comparative study between the severe and the mild/moderate types in a group of children from consanguineous families. Our current study extends the phenotypic characterisations of ISH.
Sections du résumé
BACKGROUND
BACKGROUND
Infantile systemic hyalinosis (ISH) is an autosomal recessively inherited disorder. The classical natural history of the disease is characterised by hypotonia, multiple contractures, skin lesions, osteopenia, joint pain, bone fractures, persistent diarrhoea and growth deficiency.
MATERIALS AND METHODS
METHODS
Two children manifested the severe type of ISH underwent genotypic confirmation. In order to identify which other family members have inherited the disease. We included siblings and cousins in this study. The baseline tool to study other family subjects was based on the phenotypic characterisations of each child.
RESULTS
RESULTS
. Two children with the severe type of ISH showed craniosynostosis (brachycephaly and scaphocephaly) associated with multiple contractures, progressive joint osteolysis ending up with multiple joint dislocations. The full exome sequencing was carried out, revealing a previously reported heterozygous nonsense mutation с.1294С>Т and a novel heterozygous non-synonymous substitution c. 58T>A in ANTRX2 gene. Three children (sibling and cousins) manifested variable clinical manifestations relevant to ISH. Specifically, asymptoamtic skin and skeletal abnormalities of hypoplastic clavicles and 'shepherd's crook' deformity and coxa vara.
CONCLUSION
CONCLUSIONS
It is mandatory to perform extensive family pedigree search to detect asymptomatic clinical features in siblings and cousins in families with first degree related marriages. Interestingly, in the mild and the moderate types of ISH, we observed undescribed combination of asymptomatic skin and skeletal abnormalities. This is a comparative study between the severe and the mild/moderate types in a group of children from consanguineous families. Our current study extends the phenotypic characterisations of ISH.
Identifiants
pubmed: 34341308
pii: AfrJPaediatrSurg_2021_18_4_224_322779
doi: 10.4103/ajps.AJPS_162_20
pmc: PMC8423165
doi:
Substances chimiques
Receptors, Peptide
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
224-230Déclaration de conflit d'intérêts
None
Références
Hum Mutat. 2009 Apr;30(4):583-9
pubmed: 19191226
Acta Paediatr. 2001 Jun;90(6):705-6
pubmed: 11440109
J Cell Sci. 2001 Aug;114(Pt 15):2755-73
pubmed: 11683410
Birth Defects Orig Artic Ser. 1975;11(5):57-62
pubmed: 56200
J Am Acad Dermatol. 2004 Feb;50(2 Suppl):S61-4
pubmed: 14726869
Infect Immun. 2009 Jan;77(1):52-9
pubmed: 18936178
J Clin Periodontol. 2005 Sep;32(9):1016-21
pubmed: 16104968
Eur J Paediatr Neurol. 2003;7(6):401-6
pubmed: 14623219
Am J Med Genet. 2001 Apr 22;100(2):122-9
pubmed: 11298373
Clin Exp Rheumatol. 2005 Sep-Oct;23(5):717-20
pubmed: 16173255
Proc Natl Acad Sci U S A. 2009 Jul 28;106(30):12424-9
pubmed: 19617532
J Dermatol Sci. 2009 Sep;55(3):197-200
pubmed: 19592224
Am J Hum Genet. 2003 Oct;73(4):791-800
pubmed: 14508707
Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5170-4
pubmed: 12700348
Nat Commun. 2017 Jun 12;8:15861
pubmed: 28604699
EMBO Mol Med. 2011 Apr;3(4):208-21
pubmed: 21328543
Br J Dermatol. 2010 Jul;163(1):213-5
pubmed: 20331448
Afr J Paediatr Surg. 2016 Jul-Sep;13(3):125-30
pubmed: 27502880
Pediatrics. 1991 Feb;87(2):228-34
pubmed: 1702887
Nat Genet. 2010 Feb;42(2):123-7
pubmed: 20062062
Pediatrics. 2006 Nov;118(5):e1485-92
pubmed: 17043134
Oncogene. 2010 Feb 11;29(6):789-801
pubmed: 19901963
BMC Med Genet. 2018 May 25;19(1):87
pubmed: 29801470
Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1420-4
pubmed: 20080640
Pediatr Dermatol. 2001 Sep-Oct;18(5):400-2
pubmed: 11737684
Am J Hum Genet. 2003 Oct;73(4):957-66
pubmed: 12973667
Hum Mutat. 2018 Dec;39(12):1752-1763
pubmed: 30176098
Clin Dysmorphol. 2004 Oct;13(4):231-6
pubmed: 15365459
Pediatr Dermatol. 1994 Mar;11(1):52-60
pubmed: 7513419
Pediatr Pathol. 1986;6(1):55-79
pubmed: 2434938
Ann Rheum Dis. 2014 Nov;73(11):2054-8
pubmed: 25169729
J Cell Biol. 2006 Jan 16;172(2):309-20
pubmed: 16401723
Arch Fr Pediatr. 1978 Dec;35(10):1063-74
pubmed: 86330
Pediatr Dermatol. 2004 Mar-Apr;21(2):154-9
pubmed: 15078358
Arch Dis Child. 1997 Nov;77(5):436-40
pubmed: 9487969
EMBO J. 2012 Jan 4;31(1):3-13
pubmed: 22215446
Br J Dermatol. 2007 Nov;157(5):1037-9
pubmed: 17725672